Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

The YMCA’s Diabetes Prevention Program (YMCA’s DPP) for the Treatment of Nonalcoholic Fatty Liver Disease

Clinical Trial Details

This study is for men and women who participate in the YMCA's Diabetes Prevention Program (YMCA's DPP) and have been diagnosed with non-alcoholic fatty liver disease (NAFLD). There will be no administration of study drug. The purpose of this study is to see if participation in the YMCA's DPP will result in weight loss and improvement in the liver in patients with fatty liver disease. 
Eligible participants will visit Weill Cornell Medical College Gastroenterology and Hepatology clinic to review their medical history, physical examination, complete a survey, and conduct imaging tests (FibroScan, ultrasound, DEXA scan) for their baseline visit. Blood will be collected as part of standard practice. An additional blood sample will be collected for storage. Subjects will complete 9 out of 16 weekly sessions. The YMCA's program will be conducted at Weill Cornell Medical College Gastroenterology and Hepatology Division. 
Participants will be in the study for about 1 year. 
Participants will be compensated for their time. 

Key Eligibility: 

   1. Men and women over 18 years of age. 
   2. Diagnosed with Non-alcoholic Fatty liver disease. 
   3. Detailed eligibility reviewed when contacting the study team. 

Study contact by location

Upper East Side - Manhattan


Mallory Ianelli, RN, BSN
(646) 962-4040

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:



Open to Enrollment

Age Group